In order to achieve Universal Health Coverage (UHC), the government has placed a strong emphasis on health products and technologies (HPTs).
The government is actively developing measures to guarantee the creation of locally produced, long-lasting, and affordable solutions to satisfy our healthcare demands.
The Kenya Primate Research Institute (KIPRE), which is at the forefront of conducting research in many areas, including phage therapy for Antibiotic-Resistant Bacteria, an alternative therapy, was visited by Principal Secretary of the State Department for Public Health and Professional Standards, Mary Muthoni.
The Principal Secretary emphasised the significance of such solutions during her visit to the Institute, particularly in light of the rise of antibiotic-resistant cases like Super Gonorrhoea.
The Institute is also engaged in numerous projects related to reproductive health, including a regional anti-venom vaccination.
The Ministry of Health is devoted to helping KIPRE in their efforts to improve HPT access and sustainability in the direction of UHC.
By doing this MOH seeks to develop a stronger and more dependable healthcare system for all Kenyans through funding local initiatives and research.
